Skin infection diagnostics, delivered next day
- Highest sensitivity and specificity test available
- Definitive diagnosis enables effective therapy decisions
- Next day test results to drive faster patient care
- Simple skin scraping collection technique
Learn more about adding DermSTAT testing to your patient care algorithm
Complete the form below and your local sales account manager will reach out to answer your questions about StrataDx DermSTAT™ Skin Infection PCR testing.
*Pending availability in NY.
DermSTAT Skin Infection PCR Tests
BACTERIAL
Staphylococcus aureus
Streptococcus pyogenes
(Group A Streptococcus)
mecA gene detection
(methicillin resistance)
VIRAL
Herpes Simplex Virus (HSV-1)
Herpes Simplex Virus (HSV-2)
Varicella Zoster Virus (VZV)
MYCOSIS
Dermatophytes
Candida spp
Malassezia spp
SCABIES+
Sarcoptes scabiei
Co/Secondary
Infection options:
Bacterial Panel
Mycosis Panel
WEB SPACE
Dermatophytes
Candida spp
Corynebacterium minutissimum
Pseudomonas aeruginosa
Staphylococcus aureus*
*If positive, reflex to mecA (methicillin resistance)
Comparison of Tests
| Culture | DermSTAT™ Bacterial PCR Test | |
|---|---|---|
| Turnaround Time | 2-3 days | Next day |
| Sensitivity | 85-90% | 95-100%1 |
| Specificity | 95% | 95-100%1 |
1 Internal validation study compared to Sanger DNA sequencing.
| Culture | Tzanck | DermSTAT™ Viral PCR Test | |
|---|---|---|---|
| Turnaround Time | 1-7 days | Same day | Next day |
| Sensitivity | 50-75%2 | 60-80%3 | 98-100%4 |
| Specificity | 100%2 | 90-93%3 | 98-100%4 |
2 Can J Infect Dis Med Microbiol. 2005 Mar-Apr; 16(2): 92–98.
3https://emedicine.medscape.com/article/231927-workup; Indian Dermatol Online J. 2015 Nov-Dec;6(6):381-6. ;Genitourin Med. 1988 Aug;64(4):249-54.
4 Internal validation study compared to FDA-approved PCR test for HSV1, HSV2, and VZV.
| Culture | Histopathology | KOH / Wet Prep | DermSTAT™ Mycosis PCR Test | |
|---|---|---|---|---|
| Turnaround Time | 3-28 days | 2-3 days | Same day | Next day |
| Sensitivity | 59%5 | 85-90%5 | 73-91%6 | 92-100%7 |
| Specificity | 82%5 | 72%5 | 42-91%6 | 97-100%8 |
5 J Am Acad Dermatol. 2003 Aug;49(2):193-7.
6 Jacob Oren Levitt, Barrie H. Levitt, Arash Akhavan, and Howard Yanofsky, “The Sensitivity and Specificity of Potassium Hydroxide Smear and Fungal Culture Relative to Clinical Assessment in the Evaluation
of Tinea Pedis: A Pooled Analysis,” Dermatology Research and Practice, vol. 2010, Article ID 764843, 8 pages, 2010; Journal of Basic & Clinical Medicine 2016; 5(2):4-6
7 Internal validation study compared to NYS Dermatophyte and NYS Candida.
8 Internal validation study compared to NYS Dermatophyte, NYS Candida, and Sanger DNA sequencing.
| Histopathology | KOH / Wet Prep | DermSTAT™ Scabies+ PCR Test | |
|---|---|---|---|
| Turnaround Time | 2-3 days | Same day | Next day |
| Sensitivity | 59%9 | 73-91%10 | 92-100%11 |
| Specificity | 100%9 | 42-91%10 | 97-100%11 |
9 J Clin Microbiol. 2015 Jul;53(7):2095-102.
10 Internal validation study compared to NYS Dermatophyte and NYS Candida.
11 Internal validation study compared to NYS Dermatophyte, NYS Candida, and Sanger DNA sequencing.
| Culture | Histopathology | KOH (fungal) | DermSTAT™ Web Space PCR Test | |
|---|---|---|---|---|
| Turnaround Time | 2-28 days | 2-3 days | Same day | Next day |
| Sensitivity | 50-75% | 85-90%12 | 73-91%13 | 94-100%14 |
| Specificity | 100% | 72%12 | 42-91%13 | 97-100%14 |
12 J Am Acad Dermatol. 2003 Aug;49(2):193-7.
13 Jacob Oren Levitt, Barrie H. Levitt, Arash Akhavan, and Howard Yanofsky, “The Sensitivity and Specificity of Potassium Hydroxide Smear and Fungal Culture Relative to Clinical Assessment in the Evaluation
of Tinea Pedis: A Pooled Analysis,” Dermatology Research and Practice, vol. 2010, Article ID 764843, 8 pages, 2010; Journal of Basic & Clinical Medicine 2016; 5(2):4-6
14 Internal validation study compared to NYS Dermatophyte, NYS Candida, and Sanger DNA sequencing.
What is DermSTAT™?
DermSTAT™ panels are diagnostic skin tests that use PCR to detect causative agents of skin infections, with next day results. Each panel was specially developed for clinicians to address their differential diagnostic considerations. There are currently five different panels that differentiate important microbial agents causing skin infections. The tests use real-time polymerase chain reaction (RT-PCR) technology. Based on years of research and experience in PCR-based testing, DermSTAT™ panels deliver rapid and accurate results to enable your practice to provide the best patient care.
When should you use DermSTAT™?
While clinical diagnosis may be correct, many skin infections have similar presentations. Misdiagnosis often leads to treatment failures, unnecessary prescriptions with possible side effects, and delays in accurate therapy. Order a DermSTAT™ test to ensure fast, definitive diagnosis, effective initial therapy, and increased patient satisfaction.
What are the advantages DermSTAT™ offers my practice?
DermSTAT™ optimizes your practice with faster turnaround time (next-day results), higher accuracy, and definitive diagnosis. This allows for effective initial therapy and quicker patient management. Additionally, eliminating conventional, low accuracy testing in-house gives you and your team more time to focus on patient care.
Learn more about adding DermSTAT testing to your patient care algorithm
Complete the form below and your local sales account manager will reach out to answer your questions about StrataDx DermSTAT™ Skin Infection PCR testing.
*Pending availability in NY.